Additional factors that could improve cost-effectiveness of pharmacogenetic-guided dosing in warfarin therapy.
Geisler BP; Levin-Scherz JK; Annals Of Internal Medicine, 2009, vol. 151, issue 1, p 71; author, ISSN 15393704. ISBN 15393704.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef